Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer. | Biology (Basel) | 2023 | 37237509 | PubTator, text mining | PubMed |
| Cell-based optimization and characterization of genetically encoded location-based biosensors for Cdc42 or Rac activity. | J Cell Sci | 2023 | 37226883 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| Transcriptional Regulation Technology for Gene Perturbation in Fission Yeast. | Biomolecules | 2023 | 37189462 | PubTator, text mining | PubMed |
| Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 | 37188939 | PubTator, text mining | PubMed |
| Molecular In-Depth Characterization of Chondrosarcoma for Current and Future Targeted Therapies. | Cancers (Basel) | 2023 | 37174021 | PubTator, text mining | PubMed |
| Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies. | Cancers (Basel) | 2023 | 37173999 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| CRISPR/Cas9 Genome Editing for Tissue-Specific In Vivo Targeting: Nanomaterials and Translational Perspective. | Adv Sci (Weinh) | 2023 | 37166046 | PubTator, text mining | PubMed |
| Mitotic clustering of pulverized chromosomes from micronuclei. | Nature | 2023 | 37165191 | PubTator, text mining | PubMed |
| A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma. | Cancer Med | 2023 | 37148554 | PubTator, text mining | PubMed |
| Low temperature and mTOR inhibition favor stem cell maintenance in human keratinocyte cultures. | EMBO Rep | 2023 | 37139607 | PubTator, text mining | PubMed |
| Nature-inspired protein ligation and its applications. | Nat Rev Chem | 2023 | 37117416 | PubTator, text mining | PubMed |
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres. | Cell | 2023 | 37075754 | PubTator, text mining | PubMed |
| Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment. | Front Immunol | 2023 | 37063900 | PubTator, text mining | PubMed |
| Recent advances in CAR T-cell therapy for lymphoma in China. | Clin Transl Oncol | 2023 | 37062016 | PubTator, text mining | PubMed |
| Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. | Blood Cancer J | 2023 | 37055414 | PubTator, text mining | PubMed |
| Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. | Molecules | 2023 | 37049920 | PubTator, text mining | PubMed |
| Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice. | Front Immunol | 2023 | 37033946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=11